Daily Newsletter

30 August 2023

Daily Newsletter

30 August 2023

Apollo expands connected care programme across India

The aim is to create an integrated healthcare ecosystem by collaborating with hospitals and nursing homes in urban and rural areas.

August 29 2023

Apollo, a healthcare provider in India, has announced the expansion of its connected care programme, Apollo Connect, across the country.

The aim is to create an integrated healthcare ecosystem by collaborating with hospitals and nursing homes in both urban and rural areas.

This expansion seeks to improve patient access, affordability, and experience.

The programme offers services such as eICU, diagnostics, surgical consultations, remote monitoring, clinical training, quality enhancement, and accreditation support.

By bringing together healthcare providers on a single platform, Apollo Connect aims to strengthen India's healthcare ecosystem, improve patient care, and reduce the burden of travel and logistics for patients.

Apollo founder and chairman Dr Prathap C Reddy said: “As care providers the imperative for us is to collaborate and support each other to ensure no sick person goes untreated for lack of access to quality care.

“It is with this commitment that we have created the Apollo Connect programme, an initiative towards building healthcare together, by bringing healthcare providers on one platform to provide superior care and keep patients closer to home.

“Having built and run India’s largest hospital chain, we understand the healthcare realities and challenges and have designed Apollo Connect to aid hospitals and nursing homes to improve their operational and business efficiency through exceptional service support from Apollo.

“Collaboration is an immensely powerful tool, and we believe that by coming together, we can truly strengthen India’s healthcare ecosystem and ensure every individual gets the right support they need.”

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close